BCBS Michigan will no longer cover GLP-1 agonist weight loss drugs like Zepbound, Wegovy, and Saxenda from January 1, 2025

effectively uh basically buying them sort of off the shelf and illegally per se through online sources well what's the issue with that well according to a twenty twenty four study the actual purity of some of these compounds is anywhere from 7.7 to 14.3 percent in this sample from this this study uh that's definitely concerning because you can see that if you're not getting the right dose you could have adverse effects or you may try to take more right well the other other issues patients have tried other medications like say or excuse me supplements like berberine we talked about this in our second video berberine helps with the insulin response it can help a lower blood sugar some people say it's sort of like the natural glp but it really isn't it acts on a different completely different pathway and so what patients sometimes will do is double up they'll they'll have berberine or this gray market glp or the gray market glp is just berberine right and so they don't really know what they're getting and that's the issue with not having that regulation and and inspection so what does this mean well poison control calls over the last several years are up over one thousand percent uh related to complications from GLP, particularly injections and mixing

According to recent research published in medical journals, retatrutide achieved up to 24.2% mean weight loss after 48 weeks in individuals with obesity
[53] The mechanism of action for Rimonabant was cannabinoid receptor CB1 antagonism, in other words, blocking the cannabinoid receptor (the one that weed, for example, binds to and activates in order to make you all happy)
Many weight loss medications reduce both fat and muscle
This means if you have 10-19 pounds to lose and likely don't fit into the BMI number required, they are still able to prescribe and help you achieve the weight loss you so desperately desire